Robuta

https://www.ajmc.com/view/bispecific-sequencing-crs-risk-and-celmods-navigating-the-evolving-second-line-rrmm-landscape Bispecific Sequencing, CRS Risk, and CELMoDs: Navigating the Evolving Second-Line RRMM Landscape |... Oct 13, 2026 - Learn how myeloma experts sequence BCMA vs GPRC5D bispecifics, manage CRS with prophylactic tocilizumab, and plan for CELMoDs. second linebispecificsequencingcrsrisk https://experts.umn.edu/en/publications/a-bispecific-recombinant-cytotoxin-dtegf13-targeting-human-interl/fingerprints/ A bispecific recombinant cytotoxin (DTEGF13) targeting human interleukin-13 and epidermal growth... epidermal growthbispecificrecombinantcytotoxintargeting https://healthtree.org/video/vDV37djwSembUHYDU2kD Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024 Learn about cevostamab as a novel target bispecific antibody for relapsed/refractory multiple myeloma. bispecific antibodyrrmmjoshuarichter https://www.biocentury.com/article/635556 BioCentury - Bispecific constructs move beyond T cell engagers at AACR T cell engagers have dominated the bispecific antibody scene for the past five years, but the industry is starting to branch out into next-generation struc... t cellbispecificconstructsmovebeyond https://www.creative-biolabs.com/bsab/bispecific-cd3-fap-diabody-ch3-8654.htm Recombinant Human Anti-CD3 x Human Anti-FAP Bispecific Antibody (Diabody-CH3) (BSDBC-H256) -... Creative Biolabs can provide Recombinant Human Anti-CD3 x Human Anti-FAP Bispecific Antibody (Diabody-CH3) bispecific antibodyrecombinanthumanfapdiabody https://mymedflix.com/courses/4979/2025-mls-washington-dc-egfr-tki-plus-egfr-met-bispecific-antibody Courses | 2025 MLS Washington DC | EGFR TKI Plus EGFR/Met Bispecific Antibody | MyMedFlix washington dcbispecific antibodycoursesmlsegfr https://www.fiercebiotech.com/biotech/genmab-pays-8b-buy-merus-and-phase-3-stage-bispecific-wowed-analysts? Genmab pays $8B to buy Merus and phase 3-stage bispecific Sep 29, 2025 - Genmab is continuing to build its pipeline of wholly owned cancer assets, this time paying $8 billion for Merus and its bispecific antibody. to buygenmabpaysmerusphase https://kodiak.com/file/development-of-anti-inflammatory-bispecific-trap-antibodies/ Development of Anti-inflammatory Bispecific Trap-antibodies - Kodiak Sciences developmentantiinflammatorybispecifictrap https://www.precedenceresearch.com/press-release/bispecific-antibodies-cdmo-market Bispecific Antibodies CDMO Market Drivers and Opportunities The global bispecific antibodies CDMO market solutions offer high-precision bioprocessing and outsourcing expertise for bispecific development explore market... bispecific antibodiescdmomarketdriversopportunities https://powerfulpatients.org/resource/proactive-steps-for-supporting-your-loved-one-through-bispecific-antibody-therapy/ Proactive Steps for Supporting Your Loved One Through Bispecific Antibody Therapy - Patient... Aug 18, 2025 - https://vimeo.com/1033569462 How can you best care for a loved one who is undergoing bispecific antibody therapy? Dr. Craig Cole, a myeloma specialist,... loved onebispecific antibodyproactivestepssupporting https://vantage-research.net/poster/adc-bispecific-efficacy-prediction/ Predicting efficacy of antibody drug conjugate (ADC) combined with aPD-1 x aVEGF bispecific... antibody drug conjugatepredictingefficacyadccombined https://www.invenra.com/blog/tag/bispecific-antibodies Insights from Invenra | Bispecific Antibodies Bispecific Antibodies | Get the latest insights in antibody discovery from the Invenra bench. bispecific antibodiesinsights https://ncoda.org/courses/education-and-training-for-staff-and-patients-regarding-bispecific-t-cell-engagers/ Education and Training for Staff and Patients Regarding Bispecific T-Cell Engagers Feb 19, 2026 - Empowering the Medical Oncology Pharmacy Practic education and trainingfor staffpatientsregardingbispecific https://www.astrazeneca.com/r-d/innovation-in-medicines/bispecific-antibody.html Bispecific antibody Learn more about the next generation of bispecific antibodies and their potential in refractory or resistant forms of cancer. bispecific antibody https://www.internationalfoodservicesreporter.com/article/945740502-leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig-lbl-024-granted-orphan-drug-designation-in-japan-further-expanding-global-regulatory Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug... bispecific antibodyorphan drugleadsbiolabslbl https://www.creative-biolabs.com/bsab/bispecific-cd3-fap-f-ab-2-scfv2-9543.htm Recombinant Anti-CD3 x Anti-FAP Bispecific Antibody (F(ab')2-scFv2) (BABFV-080) - Creative Biolabs Creative Biolabs can provide Recombinant Anti-CD3 x Anti-FAP Bispecific Antibody (F(ab')2-scFv2) bispecific antibodyrecombinantfapcreativebiolabs https://www.creative-biolabs.com/bsab/bispecific-cd3-gpa33-igg-fv-10259.htm Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (IgG-Fv) (BSGV-086) - Creative Biolabs Creative Biolabs can provide Recombinant Anti-CD3 x Anti-gpA33 Bispecific Antibody (IgG-Fv) bispecific antibodyrecombinantiggcreativebiolabs https://europeanmorning.com/article/904676107-leads-biolabs-opamtistomig-pd-l1-4-1bb-bispecific-antibody-advances-to-expansion-phase-in-first-line-biliary-tract-cancer-following-positive-safety Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in... European Morning Report is an online news publication focusing on the Europe: Your daily news update on Europe bispecific antibodyphase inleadsadvancesexpansion https://www.creative-biolabs.com/bsab/bispecific-cd3-muc1-miniantibody-6539.htm Recombinant Human Anti-CD3 x Human Anti-MUC1 Bispecific Antibody (Miniantibody) (MNAB-H271) -... Creative Biolabs can provide Recombinant Human Anti-CD3 x Human Anti-MUC1 Bispecific Antibody (Miniantibody) bispecific antibodyrecombinanthumanminiantibody https://www.creative-biolabs.com/bsab/bispecific-ca125-her2-miniantibody-6293.htm Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Miniantibody) (MNAB-025) - Creative Biolabs Creative Biolabs can provide Recombinant Anti-CA125 x Anti-HER2 Bispecific Antibody (Miniantibody) bispecific antibodyrecombinantminiantibodycreativebiolabs https://digitalcommons.library.tmc.edu/uthgsbs_docs/1679/ "Preclinical Development of 1B7/CD3, a Novel Anti-Tslpr Bispecific Anti" by Ze Tian, Chunhua Shi et... Patients harboring CRLF2-rearranged B-lineage acute lymphocytic leukemia (B-ALL) face a 5-year survival rate as low as 20%. While significant gains have been... preclinical developmentnovelantitslprbispecific https://www.ajmc.com/view/advance-planning-eases-bispecific-therapy-burden-for-patients Advance Planning Eases Bispecific Therapy Burden for Patients | AJMC Oct 7, 2026 - Community oncologists are steadily adopting bispecific antibodies for myeloma, but advance planning and tocilizumab remain key to safe access. for patientsadvanceplanningeasesbispecific https://www.jnj.com/media-center/press-releases/johnson-johnson-to-obtain-rights-to-a-clinical-stage-bispecific-antibody-to-address-distinct-patient-needs-in-atopic-dermatitis Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct... Feb 20, 2025 - The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational,... bispecific antibodyjohnsonobtainrightsclinical https://www.creative-biolabs.com/bsab/bispecific-cd28-cd30-minibody-4549.htm Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Minibody) (MiniB-055) - Creative Biolabs Creative Biolabs can provide Recombinant Anti-CD28 x Anti-CD30 Bispecific Antibody (Minibody) bispecific antibodyrecombinantminibodycreativebiolabs https://research.buaa.edu.cn/en/publications/a-new-egfr-and-c-met-bispecific-nir-ii-fluorescent-probe-for-visu/ A new EGFR and c-Met bispecific NIR-II fluorescent probe for visualising colorectal cancer and... a newcolorectal canceregfrmetbispecific https://littlebunker.com/2026/09/16/research_papers-discovery-and-development-of-a-bispecifi-1b45c861/ Discovery and development of a bispecific antibody for the treatment of hemophilia | Observations... Sep 16, 2026 - Proceedings of the National Academy of Sciences, Volume 123, Issue 37, September 2026 of abispecific antibodyfor thediscoverydevelopment https://www.pressrelease.com/news/100-of-patients-achieve-remission-within-30-days-in-cohort-1-of-22485723 100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline... Two of three patients achieved both complete remission and MRD-negative statusHigh response rates observed in earlier studies continue in ongoing mipletamig... patientsachieveremissionwithindays https://getfincorp.com/2026/09/09/cms-initial-prescriptions-for-silevimig-injection-the-worlds-first-bispecific-antibody-against-rabies-issued-in-china/ CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against... bispecific antibodycmsinitialprescriptionsinjection https://www.creative-biolabs.com/bsab/bispecific-egfr-igf1r-fab-scfv-scfv-3291.htm Recombinant Human Anti-EGFR x Anti-IGF1R Bispecific Antibody (Fab-scFv-scFv) (TRIB-H325) - Creative... Creative Biolabs can provide Recombinant Human Anti-EGFR x Anti-IGF1R Bispecific Antibody (Fab-scFv-scFv) bispecific antibodyrecombinanthumanegfrfab https://www.zymeworks.com/publications/world-bispecific-t-cell-engager-summit-south-korea/ ZW1528, a Bispecific Antibody Targeting IL-4Ra and IL-33 Potently Inhibits Key Mediators of Airway... Jun 25, 2026 - ZW1528, a Bispecific Antibody Targeting IL-4Ra and IL-33 Potently Inhibits Key Mediators of Airway Inflammation bispecific antibodytargetingpotentlyinhibitskey https://www.globenewswire.com/news-release/2020/03/03/1993937/0/en/Abpro-Forms-Strategic-Partnership-to-Advance-Two-Bispecific-Antibody-Candidates-in-Asian-Markets.html Abpro Forms Strategic Partnership to Advance Two Bispecific Abpro to receive up to $1.1 billion, including a $30 million upfront equity investment, clinical funding, milestones, and royalties Abpro grants... strategic partnershipformsadvancetwobispecific https://www.oregontechnologytoday.com/article/864216738-crescent-biopharma-to-present-preclinical-data-for-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-the-society-for-immunotherapy-of-cancer-s-sitc-40th Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at... bispecific antibodycrescentbiopharmapresentpreclinical https://www.creative-biolabs.com/bsab/bispecific-cd3-epcam-crossmab-2903.htm Recombinant Human Anti-CD3 x Anti-EPCAM Bispecific Antibody (CrossMab) (CROSSAB-H253) - Creative... Creative Biolabs can provide Recombinant Human Anti-CD3 x Anti-EPCAM Bispecific Antibody (CrossMab) bispecific antibodyrecombinanthumanepcamcreative https://www.creative-biolabs.com/bsab/bispecific-cea-tnf-tandem-scfv-2323.htm Recombinant Human Anti-CEA x Anti-TNFα Bispecific Antibody (Tandem scFv) (BSFV-H309) - Creative... Creative Biolabs can provide Recombinant Human Anti-CEA x Anti-TNFα Bispecific Antibody (Tandem scFv) bispecific antibodyrecombinanthumanceatandem https://www.bispecificantibodycongress.com/ Bispecific Antibody Pipeline Congress The Bispecific Antibody Pipeline Congress unites key opinion leaders including regulators, clinicians, and industry experts to deepen our understanding of... bispecific antibodypipelinecongress https://powerfulpatients.org/resource/how-is-bispecific-antibody-therapy-administered/ How Is Bispecific Antibody Therapy Administered? - Patient Empowerment Network Aug 18, 2025 - https://vimeo.com/940909156 How is myeloma bispecific antibody therapy given to patients? Nurse practitioner Alexandra Distaso from Dana-Farber Cancer... bispecific antibodypatient empowermenttherapyadministerednetwork https://straitsresearch.com/report/bispecific-antibodies-market Bispecific Antibodies Market Size, Share, Growth, Analysis, 2034 The bispecific antibodies market size is projected to grow from $11.39 billion in 2026 to $42.11 billion by 2034, at a CAGR of 17.76% during the forecast... bispecific antibodiesmarket sizesharegrowthanalysis https://microbiozindia.com/cipla-sbp-group-sign-exclusive-license-for-her2-bispecific-adc/ Cipla, SBP Group Sign Exclusive License for HER2 Bispecific ADC Latest news and Information on Pharma, Laboratory and Analytical Industry. The contents include marketing, strategy, research, drug quality, and lab equipment... exclusive licenseciplasbpgroupsign https://www.creative-biolabs.com/bsab/bispecific-cd133-egfr-scfv-fc-scfv-7186.htm Recombinant Human Anti-CD133 x Human Anti-EGFR Bispecific Antibody (scFv-Fc-scFv) (BSTF-H208) -... Creative Biolabs can provide Recombinant Human Anti-CD133 x Human Anti-EGFR Bispecific Antibody (scFv-Fc-scFv) bispecific antibodyrecombinanthumanegfrscfv https://researchoutput.ncku.edu.tw/zh/studentTheses/design-of-anti-vegfr2-and-integrin-v%CE%B23-bispecific-fusion-proteins/ Design of anti-VEGFR2 and -integrin ?vβ3 Bispecific Fusion Proteins Using Different Types and... fusion proteinsdifferent typesdesignantiintegrin https://www.citedrive.com/en/discovery/a-phase-1-study-of-cd38-bispecific-antibody-xmab18968-for-patients-with-relapsedrefractory-t-cell-acute-lymphoblastic-leukemia/ [PDF] A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with Relapsed/Refractory... Background: Outcomes of adults with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) has remained poor. CD38 is a transmembrane glycoprotein... bispecific antibodyfor patientspdfphasestudy https://healthtree.org/video/KVkzw4u58eoRkTpcXSZG Bispecific Antibody Use After CAR-T Failure for B-Cell Lymphoma | Megan Melody, MD, MS | #ASH24 Dr. Megan Melody discusses the use of bispecific antibodies for B-cell lymphoma patients that CAR-T therapy had previously failed for. b cell lymphomabispecific antibodyusecarfailure https://www.pharmasalmanac.com/articles/bispecific-antibodies-move-into-the-heme-onc-mainstream Bispecific Antibodies Move Into the Heme-Onc Mainstream As bispecific antibodies move earlier in treatment and into combination regimens, developers must solve a wider set of questions around sequencing,... bispecific antibodiesmove intohemeoncmainstream https://en.tokyofuturestyle.com/acrobiosystems-cd3 ACROBiosystems – CD3 – Hot target for bispecific antibody|Tokyo Future Style, Inc. Introducing Bispecific antibody target CD3 provided by ACROBiosystems. hot targetbispecific antibodytokyofuturestyle https://www.biotech-now.co.uk/article/418296/roches-genentech-inks-1.5b-bispecific-pact-with-fastrising-earendil Roche's Genentech inks $1.5B bispecific pact with fast-rising Earendil Sep 25, 2026 - Roche’s Genentech is paying Earendil Labs $55 million upfront to discover and develop multiple bispecific antibodies. The deal, which focuses on on... rochegenentechinksbispecificpact https://microcaps.com/medical-equipment-supplies/aethlon-medical-north-immunology-announce-merger-to-advance-novel-il-13-x-il-18-bispecific-antibody-for-atopic-dermatitis/ Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific... Sep 17, 2026 - North Immunology’s lead program, NOR-101, is a half-life extended anti-IL-13 x IL-18 bispecific antibody designed to inhibit both type 2 and non-type 2... medicalnorthimmunologyannouncemerger https://www.fiercebiotech.com/biotech/genentech-inks-15b-bispecific-pact-fast-rising-earendil Roche's Genentech inks $1.5B bispecific pact with fast-rising Earendil | Fierce Biotech Sep 25, 2026 - Roche’s Genentech is rochegenentechinksbispecificpact https://www.financetailored.com/2026/09/09/cms-initial-prescriptions-for-silevimig-injection-the-worlds-first-bispecific-antibody-against-rabies-issued-in-china/ CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against... bispecific antibodycmsinitialprescriptionsinjection